Real-world symptoms, disease burden, resource use and quality of life in US patients with advanced renal cell cancer

Real-world symptoms, disease burden, resource use and quality of life in US patients with advanced renal cell cancer

To assess symptoms, healthcare resource utilization and health-related quality of life in advanced renal cell carcinoma (aRCC) clinical practice. The USA point-in-time survey of physicians and patients was conducted between February and September 2019. Data were available for 227 patients. Mean (sta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Future oncology (London, England) England), 2021-06, Vol.17 (17), p.2169-2182
Hauptverfasser: Hall, Jennifer, Zanotti, Giovanni, Kim, Ruth, Krulewicz, Stan, Leith, Andrea, Bailey, Abigail, Liu, Frank X., Kearney, Mairead
Format: Artikel
Sprache:eng
Schlagworte:
advanced RCC
disease burden
healthcare resource utilization
Life Sciences & Biomedicine
Oncology
patient-reported outcomes
real-world treatment
Science & Technology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To assess symptoms, healthcare resource utilization and health-related quality of life in advanced renal cell carcinoma (aRCC) clinical practice. The USA point-in-time survey of physicians and patients was conducted between February and September 2019. Data were available for 227 patients. Mean (standard deviation) number of symptoms was 3.4 (3.2); differences were observed across International Metastatic RCC Database Consortium risk categories (p 
ISSN:1479-6694
1744-8301
DOI:10.2217/fon-2020-1266